TD Cowen analyst Derrick Wood keeps a Buy rating on Salesforce (CRM) with a $400 price target ahead of the company’s Q4 report on February 26.

Oppenheimer analyst Brian Schwartz reiterated a Buy rating on Salesforce (CRM – Research Report) today and set a price target of $415.00. The ...

Portfolio value rises to $21.81B. Notable stake reductions were seen in GOOG, NVDA, META, MSFT, and AMZN. See more here.

We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will ...

Axsome Therapeutics reports 66% Q4 revenue growth, blockbuster potential for Auvelity, and robust pipeline progress with 3 NDA filings and key ...